Impaired Natural Killer Cell Lysis in Breast Cancer Patients with High Levels of Psychological Stress is Associated with Altered Expression of Killer Immunoglobin-Like Receptors

Journal of Surgical Research

Volumn 139, Issue 1, 2007, Pages 36-44

  Varker, Kimberly A ^a   Terrell, Catherine E ^a,b   Welt, Marilyn ^a,b   Suleiman, Samer ^a,b   Thornton, Lisa ^b   Andersen, Barbara L ^a,b   Carson III, William E ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

breast cancer; killer immunoglobulin like receptors (KIR); natural killer (NK) cells; psychologic stress

Indexed keywords

ANTIBODY; CD161 ANTIGEN; CD18 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOKINE; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2A;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CRYOPRESERVATION; CYTOLYSIS; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENTAL STRESS; NATURAL KILLER CELL; OBSERVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZATION; RATING SCALE; SCORING SYSTEM;

ADULT; AGED; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD94; BREAST NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; STRESS, PSYCHOLOGICAL;

EID: 33947606520     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.037     Document Type: Article

References (45)

1. Carlson L.E., Angen M., Cullum J., et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90 (2004) 2297
2. Andersen B.L., Kiecolt-Glaser J.K., and Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol 49 (1994) 389
3. Andersen B.L. Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 70 (2003) 590 Erratum in J Consult Clin Psychol 2003;71:481.
4. Herschbach P., Keller M., Knight L., et al. Psychological problems of cancer patients: A cancer distress screening with a cancer-specific questionnaire. Br J Cancer 91 (2004) 504
5. Iwamitsu Y., Shimoda K., Abe H., et al. Differences in emotional distress between breast tumor patients with emotional inhibition and those with emotional expression. Psychiatry Clin Neurosci 57 (2003) 289
6. Montgomery G.H., David D., Goldfarb A.B., et al. Sources of anticipatory distress among breast surgery patients. J Behav Med 26 (2003) 153
7. Morasso G., Costantini M., Baracco G., et al. Assessing psychological distress in cancer patients: Validation of a self-administered questionnaire. Oncology 53 (1996) 295
8. Sundin E.C., and Horowitz M.J. Horowitz's impact of event scale: Evaluation of 20 years of use. Psychosom Med 65 (2003) 870
9. van't Spijker A., Trijsburg R.W., and Duivenvoorden H.J. Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980. Psychosom Med 59 (1997) 280
10. Goodwin P.J., Ennis M., Bordeleau L.J., et al. Health-related quality of life and psychosocial status in breast cancer prognosis: Analysis of multiple variables. J Clin Oncol 22 (2004) 4184
11. Thomas B.C., Mohan V.N., Thomas I., et al. Development of a distress inventory for cancer: Preliminary results. J Postgrad Med 48 (2002) 16
12. Weiss D.S., Horowitz M.J., and Wilner N. The stress response rating scale: A clinician's measure for rating the response to serious life events. Br J Clin Psychol 23 (1984) 202
13. Horowitz M., Wilner N., and William A. Impact of event scale: A measure of subjective stress. Psychosom Med 41 (1979) 209
14. Sundin E.C., and Horowitz M.J. Impact of event scale: Psychometric properties. Br J Psychiatry 180 (2002) 205
15. Andersen B.L., Farrar W.B., Golden-Kreutz D., et al. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90 (1998) 30
16. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., et al. Psychological, behavioral, and immune changes after a psychological intervention: A clinical trial. J Clin Oncol 22 (2004) 3570
17. McGregor B.A., Antoni M.H., Boyers A., et al. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J Psychosom Res 56 (2004) 1
18. Bonilla F., Alvarez-Mon M., Merino F., et al. Natural killer activity in patients with breast cancer. Eur J Gynaecol Oncol 11 (1990) 103
19. Esterling B.A., Keicolt-Glaser J.K., Bodnar J.C., et al. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 13 (1994) 291
20. Esterling B.A., Kiecolt-Glaser J.K., and Glaser R. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom Med 58 (1996) 264-272
21. Garner W.L., Minton J.P., James A.G., et al. Human breast cancer and impaired NK cell function. J Surg Oncol 24 (1983) 64
22. Hebert T.B., and Cohen S. Depression and immunity: A meta-analytic review. Psychol Bull 113 (1993) 472
23. Kiecolt-Glaser J.K., Marucha W.B., Mercado A.M., et al. Slowing of wound healing by psychological stress. Lancet 346 (1995) 1194
24. Schedlowski M., Jacobs R., Stratmann G., et al. Changes in natural killer cells during acute psychological stress. J Clin Immunol 13 (1993) 119
25. Uchida A., Kolb R., and Micksche M. Generation of suppressor cells for natural killer activity in cancer patients after surgery. J Natl Cancer Inst 68 (1982) 735
26. Beitsch P., Lotzova E., Hortobagyi G., et al. Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery. Surg Oncol 3 (1994) 211
27. McCulloch P.G., and MacIntryre A. Effects of surgery on the generation of lymphokine-activated killer cells in patients with breast cancer. Br J Surg 80 (1993) 1005
28. Pollock R.E., Lotzova E., and Stanford S.D. Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. Arch Surg 126 (1991) 338
29. Pollock R.E., Lotzova E., and Stanford S.D. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors. Cancer 70 (1992) 2192
30. Farag S.S., and Caligiuri M.A. Human natural killer cell development and biology. Blood Rev 20 (2006) 123
31. Carson III W.E., Shapiro C.L., Crespin T.R., et al. Cellular immunity in breast cancer patients completing taxane treatment. Clin Cancer Res 10 (2004) 3401
32. Snyder M.R., Weyand C.M., and Goronzy J.J. The double life of NK receptors: stimulation or co-stimulation?. Trends Immunol 25 (2004) 25
33. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull 130 (2004) 601
34. Light K.C., Girdler S.S., Sherwood A., et al. High stress responsivity predicts later blood pressure only in combination with positive family history and high life stress. Hypertension 33 (1999) 1458
35. Kirschbaum C., Prussner J.C., Stone A.A., et al. Persistent high cortisol response to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 57 (1995) 468
36. Moynihan J.A. Mechanisms of stress-induced modulation of immunity. Brain Behav Immun 17 Suppl (2003) S11
37. Epel E.S., Blackburn E.H., Lin H., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101 (2004) 17312
38. Fawzy F.I., Kemeny M.E., Fawzy N.W., et al. A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47 (1990) 729
39. Fawzy F.I., Canada A.L., and Fawzy N.W. Malignant melanoma: Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 60 (2003) 100
40. Lanier L.L. Natural killer cell receptor signaling. Curr Opin Immunol 15 (2003) 308
41. Sun P.D. Structure and function of natural-killer-cell receptors. Immunol Res 27 (2003) 539
42. Farag S.S., Fehniger T.A., Ruggeri L., et al. Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect. Blood 100 (2002) 1935
43. Lin Chua H., and Brahmi Z. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant. Cell Immunol 219 (2002) 57
44. Guerra N., Guillard M., Angevin E., et al. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinoma. Blood 95 (2000) 2883
45. Nguyen S., Dhedin N., Vernant J.P., et al. VNK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: Immaturity of NK cells and inhibitory effect of NKG2A override GVL effect. Blood 105 (2005) 4135